Wu, Xiaofeng
Chinese Academy of Medical Sciences & Peking Union Medical College · Jiangsu Province Hospital
2 papers on CoChatORCID 0000-0003-4501-1101
Most cited papers
- Verified
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Xia, Y., Tang, W., Qian, X., Li, X., Cheng, F., Wang, K., Zhang, F., Zhang, C., Li, D., Song, J., et al. (2022) · Journal for ImmunoTherapy of Cancer
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 228
- Verified
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
McMillan, E. A., Ryu, M.-J., Diep, C. H., Mendiratta, S., Clemenceau, J. R., Vaden, R. M., Kim, J.-H., Motoyaji, T., Covington, K. R., Peyton, M., et al. (2018) · Cell
Computational Drug Discovery MethodsLung Cancer Treatments and Mutations
Cited by 141
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free